Steroid treatment for pseudophakic cystoid macular oedema
1 October 2021
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Cystoid macular edema, intravitreal steroids, triamcinolone
The authors present a retrospective comparison of 45 eyes of 41 patients treated with 2mg intravitreal triamcinolone (IVT group) and 50 eyes of 42 patients treated with 40mg sub-Tenons triamcinolone (STT group) for pseudophakic cystoid macular oedema (CMO). The visual...
Cystoid macular oedema following cataract surgery
1 October 2019
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
NSAIDs, cataract, cataract surgery, corticosteroids, cystoid macular oedema
This review covers the history, incidence, diagnosis, risk factors, pathophysiology and medical management of postoperative macular oedema (PCMO), with a particular emphasis on key contemporary studies and novel observations. The authors revisit the incidence of well-established risk factors including intraoperative...
Aberrant regeneration rates following traumatic oculomotor palsy
1 October 2018
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Aberrant regeneration, oculomotor nerve, steroids, synkinesis, trauma
Traumatic oculomotor nerve palsies can result in aberrant regeneration / synkinesis which impairs normal facial function. In this paper, the authors retrospectively reviewed the records of 16 patients with traumatic oculomotor nerve palsies who were treated with or without steroids....
Overview of traumatic optic neuropathy
1 August 2018
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Intracranial injury, methylprednisolone, oral steroids, traumatic optic neuropathy, visual outcome
The authors present the clinical features and role of various treatment modalities on the final vision outcome in traumatic optic neuropathy (TON). They retrospectively reviewed the records of patients with a diagnosis of TON over a four year period in...
